CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%
Get Alerts CRSP Hot Sheet
Join SI Premium – FREE
Today's IPO for CRISPR Therapeutics AG (Nasdaq: CRSP) opened for trading at $15 after pricing its initial public offering of 4,000,000 common shares at a public offering price of $14.00 per share.
Citigroup, Piper Jaffray and Barclays are acting as joint book-running managers for the offering. Guggenheim Securities is acting as co-manager.
CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rubrik, Inc. (RBRK) IPO Opens at $38.60, Priced at $32
- Marex Group (MRX) Prices 15.38M Share IPO at $19/sh
- Chinese bubble tea company Chabaidao sees shares tumble in Hong Kong market debut
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, Citi, Barclays, IPO, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!